SCHEMBL25045980

SCHEMBL25045980

COc1cc(C(C)C)ccc1S(=O)(=O)Cl

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 3/20 0.62
▸ ALDH1A1 P00352 9/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ TSHR P16473 2/20 0.45
▸ HDAC4 P56524 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ HPGD P15428 1/20 0.44
▸ ACHE P22303 2/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ RECQL P46063 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ BCHE P06276 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30184710 1.00 TRPV4 (0.62) TRPV4ALDH1A1SMN1; SMN2POLBTSHR
SCHEMBL10641518 0.86 ALDH1A1 (0.57) TRPV4ALDH1A1SMN1; SMN2POLBTSHR
SCHEMBL13450384 0.84 ALDH1A1 (0.48) TRPV4ALDH1A1SMN1; SMN2POLBTSHR
SCHEMBL16308958 0.83 ALDH1A1 (0.47) TRPV4ALDH1A1SMN1; SMN2POLBTSHR
SCHEMBL30392211 0.83 CA1 (0.50) TRPV4ALDH1A1SMN1; SMN2POLBTSHR
SCHEMBL23598878 0.83 CA1 (0.50) TRPV4ALDH1A1SMN1; SMN2POLBTSHR
SCHEMBL16259602 0.78 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2POLBTSHRHDAC4
SCHEMBL2947794 0.77 TRPV4 (1.00) TRPV4ALDH1A1POLBTSHRHPGD
SCHEMBL74997 0.77 TRPV4 (0.68) TRPV4ALDH1A1CA1CA2
SCHEMBL533956 0.77 TRPV4 (0.68) TRPV4ALDH1A1SMN1; SMN2POLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023016484-A1 SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2023-02-16 — — WO disclosed
Send feedback